Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Fostamatinib Disodium is safe and effective
in the treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP).